Jim Simons acquired 7.12 Million Corcept Therapeutics shares worth $204 Million. That's 0.34% of their equity portfolio (43rd largest holding). The investor owns 6.20% of the outstanding Corcept Therapeutics stock. The first Corcept Therapeutics trade was made in Q1 2015. Since then Jim Simons bought shares 22 more times and sold shares on fourteen occasions. The stake costed the investor $94.5 Million, netting the investor a gain of 115% so far.